April 19, 2023
Eli Lilly’s diabetes drug Mounjaro (tirzepatide), the world’s first GIP/GLP-1 dual receptor agonist, is now available in Japan. It will be marketed and distributed by local partner Mitsubishi Tanabe Pharma, with promotional activities to be jointly run by the two...read more